Portal de Periódicos da CAPES

Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia

2009; Wiley; Volume: 85; Issue: 2 Linguagem: Indonésio

10.1002/ajh.21595

1096-8652

Barbara Buldini, Andrea Zangrando, Barbara Michielotto, Marinella Veltroni, Emanuela Giarin, Francesca Tosato, Giovanni Cazzaniga, Andrea Biondi, Giuseppe Basso,

Childhood Cancer Survivors' Quality of Life

American Journal of HematologyVolume 85, Issue 2 p. 138-141 LetterFree Access Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia† Barbara Buldini, Corresponding Author Barbara Buldini [email protected] Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalyLaboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorAndrea Zangrando, Andrea Zangrando Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorBarbara Michielotto, Barbara Michielotto Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorMarinella Veltroni, Marinella Veltroni Department of Pediatrics, Hematology Oncology, A.O.U. A.Meyer, Florence, ItalySearch for more papers by this authorEmanuela Giarin, Emanuela Giarin Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorFrancesca Tosato, Francesca Tosato Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorGianni Cazzaniga, Gianni Cazzaniga Department of Pediatric Hematology and Oncology, University of Milano Bicocca, Clinica Pediatrica Ospedale San Gerardo, Monza, ItalySearch for more papers by this authorAndrea Biondi, Andrea Biondi Department of Pediatric Hematology and Oncology, University of Milano Bicocca, Clinica Pediatrica Ospedale San Gerardo, Monza, ItalySearch for more papers by this authorGiuseppe Basso, Giuseppe BassoSearch for more papers by this author Barbara Buldini, Corresponding Author Barbara Buldini [email protected] Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalyLaboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorAndrea Zangrando, Andrea Zangrando Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorBarbara Michielotto, Barbara Michielotto Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorMarinella Veltroni, Marinella Veltroni Department of Pediatrics, Hematology Oncology, A.O.U. A.Meyer, Florence, ItalySearch for more papers by this authorEmanuela Giarin, Emanuela Giarin Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorFrancesca Tosato, Francesca Tosato Laboratory of Hemato Oncology, Department of Pediatrics, University of Padua, Padua, ItalySearch for more papers by this authorGianni Cazzaniga, Gianni Cazzaniga Department of Pediatric Hematology and Oncology, University of Milano Bicocca, Clinica Pediatrica Ospedale San Gerardo, Monza, ItalySearch for more papers by this authorAndrea Biondi, Andrea Biondi Department of Pediatric Hematology and Oncology, University of Milano Bicocca, Clinica Pediatrica Ospedale San Gerardo, Monza, ItalySearch for more papers by this authorGiuseppe Basso, Giuseppe BassoSearch for more papers by this author First published: 01 December 2009 https://doi.org/10.1002/ajh.21595Citations: 7 † Conflict of interest: Nothing to report. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Radich JP. Philadelphia chromosome-positive acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001; 15: 21–36. 10.1016/S0889-8588(05)70198-2 CASPubMedWeb of Science®Google Scholar 2 Maurer J,Janssen JW,Thiel E, et al. Detection of chimeric BCR/ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1059. 10.1016/0140-6736(91)91706-Z CASPubMedWeb of Science®Google Scholar 3 van Dongen JJ,Macintyre EA,Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928. 10.1038/sj.leu.2401592 CASPubMedWeb of Science®Google Scholar 4 van der Burg M,Poulsen TS,Hunger SP, et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004; 18: 895–908. 10.1038/sj.leu.2403340 CASPubMedWeb of Science®Google Scholar 5 Schultz KR,Bowman WP,Slayton W, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A children's oncology group study. J Clin Oncol 2009; 27: 5175–5181. 10.1200/JCO.2008.21.2514 CASPubMedWeb of Science®Google Scholar 6 Fuster JL,Bermúdez M,Galera A, et al. Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 2007; 92: 1723–1724. 10.3324/haematol.11525 CASPubMedWeb of Science®Google Scholar 7 Yeoh EJ,Ross ME,Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukaemia by gene expression profiling. Cancer Cell 2002; 1: 133–143. 10.1016/S1535-6108(02)00032-6 CASPubMedWeb of Science®Google Scholar 8 Hofmann WK,de Vos S,Elashoff D, et al. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles study. Lancet 2002; 359: 481–486. 10.1016/S0140-6736(02)07678-X CASPubMedWeb of Science®Google Scholar 9 Armstrong SA,Staunton SE,Silverman LB, et al. MLL translocation specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41–47. 10.1038/ng765 CASPubMedWeb of Science®Google Scholar 10 Kern W,Kohlmann A,Wuchter C, et al. Correlation of protein expression and gene expression in acute leukemia. Cytometry B Clin Cytom 2003; 55: 29–36. 10.1002/cyto.b.10025 CASPubMedWeb of Science®Google Scholar 11 Basso G,Buldini B,De Zen L,Orfao A. New methodologic approaches for immunophenotyping acute leukemia. Haematologica 2001; 86: 675–692. CASPubMedWeb of Science®Google Scholar 12 Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059–1064. 10.1126/science.278.5340.1059 CASPubMedWeb of Science®Google Scholar 13 Williams DL,Look AT,Melvin SL, et al. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 1984; 36: 101–109. 10.1016/0092-8674(84)90078-3 PubMedWeb of Science®Google Scholar 14 Izraeli S,Janssen JW,Haas OA, et al. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 1993; 7: 671–678. PubMedWeb of Science®Google Scholar 15 Weerkamp F,Dekking E,Ng YY, et al. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients. Leukemia 2009; 23: 1106–1117. 10.1038/leu.2009.93 CASPubMedWeb of Science®Google Scholar 16 Devaraj PE,Foroni L,Janossy G et al. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia 1995; 9: 821–825. PubMedWeb of Science®Google Scholar 17 Pui CH,Behm FG,Downing JR, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994; 12: 909–915. 10.1200/JCO.1994.12.5.909 CASPubMedWeb of Science®Google Scholar 18 Borowitz MJ,Hunger SP,Carroll AJ, et al. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis. A Pediatric Oncology Group study. Blood 1993; 82: 1086–1091. CASPubMedWeb of Science®Google Scholar 19 De Zen L,Orfao A,Cazzaniga G, et al. Quantitative multiparametric imunophenotyping in acute lymphoblastic leukemia: Correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia. 2000; 14: 1225–1231. 10.1038/sj.leu.2401824 CASPubMedWeb of Science®Google Scholar 20 Borowitz MJ,Rubnitz J,Nash M, et al. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: A Pediatric Oncology Group. Leukemia 1998; 12: 1764–1770. 10.1038/sj.leu.2401177 CASPubMedWeb of Science®Google Scholar 21 Pui CH. Acute leukemias with the t(4;11)(q21;q23). Leuk Lymphoma 1992; 7: 173–179. 10.3109/10428199209053620 CASPubMedWeb of Science®Google Scholar 22 De Zen L,Bicciato S,te Kronnie G,Basso G. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification. Leukemia 2003; 17: 1557–1565. 10.1038/sj.leu.2403013 CASPubMedWeb of Science®Google Scholar 23 Ross ME,Zhou X,Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102: 2951–2959. 10.1182/blood-2003-01-0338 CASPubMedWeb of Science®Google Scholar 24 Coustan-Smith E,Mullighan CG,Onciu M, et al. Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147–156. 10.1016/S1470-2045(08)70314-0 CASPubMedWeb of Science®Google Scholar 25 Chiaretti S,Li X,Gentleman R, et al. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clin Cancer Res 2005; 11: 7209–7219. 10.1158/1078-0432.CCR-04-2165 CASPubMedWeb of Science®Google Scholar 26 Primo D,Tabernero MD,Perez JJ, et al. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: Impact on the clinical, biological and immunophenotypical disease characteristics. Leukemia 2005; 19: 713–720. 10.1038/sj.leu.2403714 CASPubMedWeb of Science®Google Scholar 27 Tabernero MD,Bortoluci AM,Alaejos I, et al. Adult precursor B-ALL with BCR-ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34 CD13 and CD38 expression. Leukemia 2001; 15: 406–414. 10.1038/sj.leu.2402060 CASPubMedWeb of Science®Google Scholar 28 Den Boer ML,van Slegtenhorst M,de Menezes RX, et al. A subtype of childhood acute lymphoblastic luekaemia with poor treatment outcome: A genome-wide classification study. Lancet Oncol 2009; 10: 125–134. 10.1016/S1470-2045(08)70339-5 CASPubMedWeb of Science®Google Scholar 29 Dyer MJ. The role of CAMPATH-1 antibodies in the treatment of lymphoid malignancies. Semin Oncol 1999; 26(5 Suppl 14 ): 52–57. CASPubMedWeb of Science®Google Scholar 30 Chevallier P,Mahe B,Garand R, et al. Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression. Int J Hematol 2008; 88: 209–211. 10.1007/s12185-008-0123-2 PubMedWeb of Science®Google Scholar Citing Literature Volume85, Issue2February 2010Pages 138-141 ReferencesRelatedInformation